Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen SG&A Expense (Quarterly): 37.74M for Sept. 30, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 37.74M |
June 30, 2023 | 36.36M |
March 31, 2023 | 40.02M |
December 31, 2022 | 42.06M |
September 30, 2022 | 33.62M |
June 30, 2022 | 23.79M |
March 31, 2022 | 16.65M |
December 31, 2021 | 13.58M |
September 30, 2021 | 10.30M |
June 30, 2021 | 9.728M |
March 31, 2021 | 10.21M |
December 31, 2020 | 9.738M |
September 30, 2020 | 10.23M |
June 30, 2020 | 9.767M |
March 31, 2020 | 8.864M |
December 31, 2019 | 9.803M |
September 30, 2019 | 9.208M |
June 30, 2019 | 8.70M |
March 31, 2019 | 10.78M |
December 31, 2018 | 9.752M |
September 30, 2018 | 8.347M |
June 30, 2018 | 8.652M |
March 31, 2018 | 9.995M |
December 31, 2017 | 9.048M |
September 30, 2017 | 7.908M |
Date | Value |
---|---|
June 30, 2017 | 8.836M |
March 31, 2017 | 8.119M |
September 30, 2016 | 9.459M |
June 30, 2016 | 9.298M |
March 31, 2016 | 11.24M |
December 31, 2015 | 8.054M |
September 30, 2015 | 8.329M |
June 30, 2015 | 7.261M |
March 31, 2015 | 7.00M |
December 31, 2014 | 6.872M |
September 30, 2014 | 7.095M |
June 30, 2014 | 6.456M |
March 31, 2014 | 6.04M |
December 31, 2013 | 5.447M |
September 30, 2013 | 6.526M |
June 30, 2013 | 5.373M |
March 31, 2013 | 4.995M |
December 31, 2012 | 5.464M |
September 30, 2012 | 5.639M |
June 30, 2012 | 5.726M |
March 31, 2012 | 5.021M |
December 31, 2011 | 4.834M |
September 30, 2011 | 4.841M |
June 30, 2011 | 4.438M |
March 31, 2011 | 4.55M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
8.70M
Minimum
Jun 2019
42.06M
Maximum
Dec 2022
18.91M
Average
10.26M
Median
SG&A Expense (Quarterly) Benchmarks
AbbVie Inc | 3.315B |
Pfizer Inc | 3.495B |
Johnson & Johnson | 5.057B |
Merck & Co Inc | 2.483B |
Cerevel Therapeutics Holdings Inc | 36.23M |